Griffin Serves as Exclusive Financial Advisor to MedAvante

MedAvante provides sophisticated clinical trial services to address the pharmaceutical industry’s need for more accurate results for clinical trials involving central nervous system drugs and, thereby, to reduce cost and the time to market for such drugs

Griffin raised equity capital for the company to fund operations and research and development including: (i) facility expansion; (ii) expand and strengthen the management team; and (iii) upgrade the company’s technological capabilities

Close
Your Privacy

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognizing you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful. The information does not usually directly identify you, but it can give you a more personalized web experience. Because we respect your right to privacy, you can choose to not allow certain types of cookies. Click on the categories on the left to find out more and change your default settings. Blocking some types of cookies may impact your experience on this website.